Section 2: Supply and Installation of One (1) Stereotactic Radiotherapy System with a Special Table and Software on an Existing Linear Accelerator to Meet the Needs of the Radiotherapy Department of the Papageorgiou General Hospital

This tender, designated as Section 2, concerns the supply and installation of a stereotactic radiotherapy system. This system includes a specialized treatment table and associated software, designed to be integrated with an existing linear accelerator at the Papageorgiou General Hospital. The primary goal is to enhance the capabilities of the hospital's Radiotherapy Department by enabling advanced stereotactic radiotherapy treatments. This technique allows for highly precise radiation delivery to target tumors while minimizing damage to surrounding healthy tissues. The scope of work involves the procurement of the complete system, its installation, and integration with the hospital's existing infrastructure. Bidders must demonstrate their expertise in providing and installing such sophisticated medical equipment. The tender documents will detail the technical specifications, performance requirements, and integration protocols. Successful implementation of this system is expected to significantly improve cancer treatment options for patients at the Papageorgiou General Hospital.

This is a supplies contract in the health and medical services sector, with a focus on Hospitals and Medical Equipment. Located in Greece, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 266,129.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.